187 related articles for article (PubMed ID: 34780561)
1. Leucine rich amelogenin peptide prevents ovariectomy-induced bone loss in mice.
Haruyama N; Yamaza T; Suzuki S; Hall B; Cho A; Gibson CW; Kulkarni AB
PLoS One; 2021; 16(11):e0259966. PubMed ID: 34780561
[TBL] [Abstract][Full Text] [Related]
2. Leucine rich amelogenin peptide alters ameloblast differentiation in vivo.
Stahl J; Nakano Y; Kim SO; Gibson CW; Le T; DenBesten P
Matrix Biol; 2013; 32(7-8):432-42. PubMed ID: 23747796
[TBL] [Abstract][Full Text] [Related]
3. Leucine-rich amelogenin peptide: a candidate signaling molecule during cementogenesis.
Boabaid F; Gibson CW; Kuehl MA; Berry JE; Snead ML; Nociti FH; Katchburian E; Somerman MJ
J Periodontol; 2004 Aug; 75(8):1126-36. PubMed ID: 15455742
[TBL] [Abstract][Full Text] [Related]
4. The receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice.
Hatakeyama J; Sreenath T; Hatakeyama Y; Thyagarajan T; Shum L; Gibson CW; Wright JT; Kulkarni AB
J Biol Chem; 2003 Sep; 278(37):35743-8. PubMed ID: 12851394
[TBL] [Abstract][Full Text] [Related]
5. Amelogenins: Multi-Functional Enamel Matrix Proteins and Their Binding Partners.
Haruyama N; Hatakeyama J; Moriyama K; Kulkarni AB
J Oral Biosci; 2011 Aug; 53(3):257-266. PubMed ID: 23914134
[TBL] [Abstract][Full Text] [Related]
6. Amelogenin-mediated regulation of osteoclastogenesis, and periodontal cell proliferation and migration.
Hatakeyama J; Philp D; Hatakeyama Y; Haruyama N; Shum L; Aragon MA; Yuan Z; Gibson CW; Sreenath T; Kleinman HK; Kulkarni AB
J Dent Res; 2006 Feb; 85(2):144-9. PubMed ID: 16434732
[TBL] [Abstract][Full Text] [Related]
7. Rescue of the murine amelogenin null phenotype with two amelogenin transgenes.
Gibson CW; Li Y; Suggs C; Kuehl MA; Pugach MK; Kulkarni AB; Wright JT
Eur J Oral Sci; 2011 Dec; 119 Suppl 1(Suppl 1):70-4. PubMed ID: 22243230
[TBL] [Abstract][Full Text] [Related]
8. Leucine-rich amelogenin peptide induces osteogenesis in mouse embryonic stem cells.
Warotayanont R; Zhu D; Snead ML; Zhou Y
Biochem Biophys Res Commun; 2008 Feb; 367(1):1-6. PubMed ID: 18086559
[TBL] [Abstract][Full Text] [Related]
9. Amelogenin splice isoforms stimulate chondrogenic differentiation of ATDC5 cells.
Mitani K; Haruyama N; Hatakeyama J; Igarashi K
Oral Dis; 2013 Mar; 19(2):169-79. PubMed ID: 22863294
[TBL] [Abstract][Full Text] [Related]
10. The small bovine amelogenin LRAP fails to rescue the amelogenin null phenotype.
Chen E; Yuan ZA; Wright JT; Hong SP; Li Y; Collier PM; Hall B; D'Angelo M; Decker S; Piddington R; Abrams WR; Kulkarni AB; Gibson CW
Calcif Tissue Int; 2003 Nov; 73(5):487-95. PubMed ID: 12958690
[TBL] [Abstract][Full Text] [Related]
11. Ovariectomy-induced bone loss in
Zhu S; He H; Gao C; Luo G; Xie Y; Wang H; Tian L; Chen X; Yu X; He C
J Mol Endocrinol; 2018 Apr; 60(3):185-198. PubMed ID: 29339399
[TBL] [Abstract][Full Text] [Related]
12. Glaucocalyxin A suppresses osteoclastogenesis induced by RANKL and osteoporosis induced by ovariectomy by inhibiting the NF-κB and Akt pathways.
Zhu M; Shan J; Xu H; Xia G; Xu Q; Quan K; Liu X; Dai M
J Ethnopharmacol; 2021 Aug; 276():114176. PubMed ID: 33933570
[TBL] [Abstract][Full Text] [Related]
13. Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice.
Wang F; Wang PX; Wu XL; Dang SY; Chen Y; Ni YY; Gao LH; Lu SY; Kuang Y; Huang L; Fei J; Wang ZG; Pang XF
PLoS One; 2013; 8(7):e68497. PubMed ID: 23844209
[TBL] [Abstract][Full Text] [Related]
14. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
[TBL] [Abstract][Full Text] [Related]
15. The naturally derived small compound Osthole inhibits osteoclastogenesis to prevent ovariectomy-induced bone loss in mice.
Zhao D; Wang Q; Zhao Y; Zhang H; Sha N; Tang D; Liu S; Lu S; Shi Q; Zhang Y; Dong Y; Wang Y; Shu B
Menopause; 2018 Dec; 25(12):1459-1469. PubMed ID: 29944638
[TBL] [Abstract][Full Text] [Related]
16. Novel LRAP-binding partner revealing the plasminogen activation system as a regulator of cementoblast differentiation and mineral nodule formation in vitro.
Martins L; Amorim BR; Salmon CR; Leme AFP; Kantovitz KR; Nociti FH
J Cell Physiol; 2020 May; 235(5):4545-4558. PubMed ID: 31621902
[TBL] [Abstract][Full Text] [Related]
17. The leucine-rich amelogenin peptide alters the amelogenin null enamel phenotype.
Gibson CW; Li Y; Daly B; Suggs C; Yuan ZA; Fong H; Simmons D; Aragon M; Kulkarni AB; Wright JT
Cells Tissues Organs; 2009; 189(1-4):169-74. PubMed ID: 18701811
[TBL] [Abstract][Full Text] [Related]
18. Increased osteoblastogenesis and decreased bone resorption protect against ovariectomy-induced bone loss in thrombospondin-2-null mice.
Hankenson KD; James IE; Apone S; Stroup GB; Blake SM; Liang X; Lark MW; Bornstein P
Matrix Biol; 2005 Aug; 24(5):362-70. PubMed ID: 15979292
[TBL] [Abstract][Full Text] [Related]
19. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
20. Enamel formation in vitro in mouse molar explants exposed to amelogenin polypeptides ATMP and LRAP on enamel development.
Ravindranath RM; Devarajan A; Bringas P
Arch Oral Biol; 2007 Dec; 52(12):1161-71. PubMed ID: 17679105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
